CBIZ, Inc. heads into the week of July 13 in a notably different place from where it started June — up 11% on the week and 16% over the past month, powered by a Q2 earnings beat that lifted both revenue and operating margin guidance.
The stock's sharp re-rating is the most interesting feature here, and what makes it worth examining is how little the short community has adjusted in response. Short interest is effectively unchanged, edging down just 0.5% over the past week to 7.2% of the free float — a level that remains genuinely meaningful for a mid-cap consulting firm. The short position has been grinding lower for a month (off 4.5% over 30 days) but there is no sign of a sharp cover-driven squeeze accompanying the rally. Borrowing costs remain cheap at 0.45% annually, up modestly week-on-week but still well within the low range. Availability in the lending pool is the opposite of stressed: roughly 365% of the existing short position remains unborrowed, meaning three and a half shares sit available for every one already lent out. Conditions are loose, not tight — the rally looks driven by buyers, not by forced covering.
Options positioning has nudged slightly more cautious as the stock rallied. The put/call ratio ticked up to 0.63 on July 14, running above its 20-day average of 0.55 by roughly 1.4 standard deviations — elevated but not extreme. The 52-week high on the PCR is 8.78, so the current reading is nowhere near stressed territory. The direction of travel is worth noting though: the ratio was closer to 0.45 through most of June before the stock started moving. Some buyers of the rally are hedging their exposure.
On the Street, the recent coverage picture is mixed in tone but skewed bullish in direction. Barrington Research started coverage in late June with an Outperform and a $45 target — the most recent action on the name and sitting above the current price of $40.92. The consensus mean target is $42.60, implying modest upside from here. Stephens initiated at Equal-Weight with a $31 target in April, and BMO started at Outperform with a $33 target in March — both now significantly below the current price following the earnings-driven rally, which raises the question of whether target revisions follow the next print on July 30. The factor scores paint a similarly split picture: the analyst recommendation divergence ranks in the 98th percentile of the universe, flagging that the Street remains unusually spread across bull and bear camps. EPS surprise scores in the 79th percentile, consistent with a company that tends to beat. The short score factor, at the 13th percentile, flags that from a short-pressure standpoint this name ranks in the bottom tier — not a squeeze candidate, but not heavily shorted relative to history either.
Institutional ownership adds a constructive layer. FMR (Fidelity) holds 14.4% of shares and added 623,000 shares through April. BlackRock added 449,000 shares through June, its most recent reported position. Burgundy Asset Management built a large stake — adding 1.26 million shares — as of the March quarter-end. On the other side, Eaton Vance trimmed by nearly 1.3 million shares and P2 Capital cut by 633,000. The net picture is that several large, longer-horizon holders have been buyers, while some others have been reducing. Jerome Grisko, CEO, holds a 2.3% stake but sold shares in February at prices in the high $20s to low $30s — now well below the current level following the Q2-driven run.
The next earnings event is July 30, and the prior Q1 print is a useful reference point: the stock fell 6.1% the day after and 8.7% over the following week. That was a different starting point — shares were in the mid-to-high $30s at that stage — but the pattern establishes that the market can react sharply to any disappointment. With the stock now up 16% in a month and consensus targets only modestly higher than the current price, the July 30 print and any guidance commentary on the pace of client spending will be the key data point to watch.
See the live data behind this article on ORTEX.
Open CBZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
